206 related articles for article (PubMed ID: 16445443)
1. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
[TBL] [Abstract][Full Text] [Related]
2. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
Kobelt-Nguyen G; Gerdtham UG; Alm A
J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
[TBL] [Abstract][Full Text] [Related]
3. Treatment of glaucoma in clinical practice: four-year results from a patient registry in France.
Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
J Glaucoma; 2010 Mar; 19(3):199-206. PubMed ID: 19661825
[TBL] [Abstract][Full Text] [Related]
4. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
[TBL] [Abstract][Full Text] [Related]
7. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
[TBL] [Abstract][Full Text] [Related]
8. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
Hagman J
Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
[TBL] [Abstract][Full Text] [Related]
9. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
Rosenbaum LJ
Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
[No Abstract] [Full Text] [Related]
11. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
Walt JG; Lee JT
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S36-44. PubMed ID: 15016560
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treating ocular hypertension.
Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
Holmstrom S; Buchholz P; Walt J; Wickstrøm J; Aagren M
Curr Med Res Opin; 2006 May; 22(5):897-905. PubMed ID: 16709311
[TBL] [Abstract][Full Text] [Related]
16. Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study.
Koleva D; Motterlini N; Schiavone M; Garattini L;
Ophthalmologica; 2007; 221(5):340-7. PubMed ID: 17728557
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
18. Health care charges for patients with ocular hypertension or primary open-angle glaucoma.
Pasquale LR; Dolgitser M; Wentzloff JN; Stern LS; Doyle JJ; Chiang TH; Walt JG
Ophthalmology; 2008 Apr; 115(4):633-638.e4. PubMed ID: 17716736
[TBL] [Abstract][Full Text] [Related]
19. Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada.
Vicente C; Walker J; Buys Y; Einarson TR; Covert D; Iskedjian M
Curr Med Res Opin; 2004 Aug; 20(8):1245-51. PubMed ID: 15324527
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
